The ABCD audit programme was prominent at the recent EASD in Madrid with three presentations.

In a short oral presentation, Dr Emma Wilmot presented data showing that in the ABCD NHS England pilot audit of hybrid closed loop therapy (HCL) which was launched in 2021, irrespective of gender, ethnicity, age or socioeconomic status HCL is associated with similar reduction in HbA1c at 6-months.

Diabetes-related ketoacidosis (DKA) is a serious complication that requires standardised, high-quality care. Despite updates to the Joint British Diabetes Societies-Inpatient (JBDS-IP) guidelines in 2010, 2013, 2021, and 2023, research has shown significant variation in DKA care between patients. Traditional audits have fallen short in addressing this variation, which demands immediate attention.

The 25th SAHF Annual Conference is taking place on the 7th and 8th November at Edgbaston Conference Centre in Birmingham.

This year marks a significant milestone as the South Asian Health Foundation (SAHF) celebrate their 25th anniversary, the theme for this landmark event is ‘Health Inequalities: Full Stop’. 

A new study which found that diabetes risk increases after glucocorticoids has made headlines, including a feature on the BBC news site. 

We are delighted to announce that registration for the Diabetes Update programme is now open!

Our much awaited initiative for trainees in diabetes and endocrinology will be held from the 29th - 31st January in Loughborough. 

Our Diabetes Update aims to cover the diabetes section of the training curriculum for diabetes and endocrinology issued by the Joint Royal Colleges of Physicians Training Board. It is also be a great opportunity for more established clinicians to find out the latest updates in the area of diabetes.

Tackling Health Inequalities and CVD Through Innovation & Leadership

This conference will run virtually across two-days on Thursday, 26th & Friday, 27th September 2024. 

Through presentations and question and answer sessions, this conference will bring together an expert faculty of primary and secondary healthcare professionals with specialisms across cardiology. A wide range of topics across cardiovascular disease including population health, health inequalities, risk assessments, cardiac rehabilitation and heart failure will be discussed.

The conference has been instigated and organised by ABCD. Sponsors* have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.

*A. Menarini Farmaceutica Internazionale ERL, AstraZeneca UK, Bayer Public Limited Company, Boehringer-Ingelheim and Lilly Alliance, Daiichi Sankyo UK, Medice UK Ltd, Novo Nordisk